The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
Bloomberg
Sinovac Biotech Ltd received regulatory approval from Chinese authorities for its coronavirus vaccine to be used by the general public
in the country’s second such authorisation.
The conditional approval was announced by the National Medical Products Administration on Saturday. Sinovac earlier said the protective efficacy of its vaccine, CoronaVac, met World Health Organization and China regulatory standards 14 days after the completion of two shots.
With the approval, the vaccine can be administered to the general population following one developed by state-owned China National Biotec Group Co which got permission in December.
The Chinese regulator
had endorsed CoronaVac for emergency use in July.
China has fallen behind the US and Europe in vaccinating its population.